Table 5 Treatment of adverse event costs and probability of occurrence for each of strategies
Adverse Events | Monthly Total AE Costs ($) | Probability of Occurrence (%) (33) | ||
|---|---|---|---|---|
Palbociclib+Letrozole | Letrozole | Ribociclib+Letrozole | ||
Neutropenia | 31.379 | 52.05 | 0.95 | 52.4 |
leukopenia | 31.379 | 21.55 | 0 | 20.1 |
Nausea | 6.743 | 1.1 | 1.4 | 2.4 |
vomiting | 6.7433 | 0.25 | 1.2 | 3.6 |
Diarrhea | 1.658 | 2.7 | 0.7 | 2.4 |
Anemia | 23.661 | 5.5 | 1.2 | 1.2 |
Pulmonary Embolism | 164.688 | 3.175 | 0.3 | 0.45 |